In experimental diabetes, Ang II (AT1) receptor expression is up regulated and Ang II (AT2) receptor is down regulated [53], whereas, PPAR-γ agonists (TZDs) have been proven to down regulate the expression of angiotensin AT1 receptor mRNA in vascular smooth muscle (VSMC) [54]. This evidence concerns the gene PPARG and diabetes mellitus.